191 results about "Biosensor device" patented technology

Disclosed are bioluminescent bioreporter integrated circuit devices that detect selected analytes in fluids when implanted in the body of an animal. The device comprises a bioreporter that has been genetically engineered to contain a nucleic acid segment that comprises a cis-activating response element that is responsive to the selected substance operably linked to a gene encoding a bioluminescent reporter polypeptide. In preferred embodiments, the target analyte is glucose, glucagons, or insulin. Exposure of the bioreporter to the target substance causes the response element to up-regulate the nucleic acid sequence encoding the reporter polypeptide to produce a luminescent response that is detected and quantitated. In illustrative embodiments, the bioreporter device is encapsulated on an integrated circuit that is capable of detecting the emitted light, processing the resultant signal, and then remotely reporting the results. Also disclosed are controlled drug delivery systems capable of being directly or indirectly controlled by the detection device that provide drugs such as insulin to the animal in reponse to the amount of target analyte present in the body fluids.

An integrated biosensor system for the simultaneously detection of a plurality of different types of targets includes at least one sampling platform, the sampling platform including a plurality of receptors for binding to the targets. The plurality of receptors include at least one protein receptor and at least one nucleic acid receptor. At least one excitation source of electromagnetic radiation at a first frequency is provided for irradiating the receptors, wherein electromagnetic radiation at a second frequency different from the first frequency is emitted in response to irradiating when at least one of the different types of targets are bound to the receptor probes. An integrated circuit detector system having a plurality of detection channels is also provided for detecting electromagnetic radiation at said second frequency, the detection channels each including at least one detector.

An implanted system for treatment of human diseases by electric stimulation and/or electric blocking of the body tissues, comprising sensor and/or biosensor means for measuring variables in the body, processor means connected to the sensors and biosensors for processing the measured variables and for deciding in real time whether to apply an electric signal to the body tissues, and electrode means implanted at predefined locations and connected to the processor means, for applying the stimulation and/or electric blocking signals to the body tissues. A method for treatment of human diseases using an implanted system by electric stimulation and/or electric blocking of the body tissues, comprising: A. measuring variables in the body using implanted sensor and/or biosensor means; B. processing the measured variables for deciding in real time whether to apply an electric signal to the body tissues; C. applying the stimulation and/or electric blocking signals to the body tissues.

An implantable biosensor system is disclosed for determining levels of cardiac markers in a patient to aid in the diagnosis, determination of the severity and management of cardiovascular diseases. The sensor includes nanowire sensor elements having a biological recognition element attached to a nanowire transducer that specifically binds to the cardiac marker being measured. Each of the sensor elements is associated with a protective member that prevents the sensor element from interacting with the surrounding environment. At a selected time, the protective member may be disabled, thereby allowing the sensor element to begin sensing signals within a living body.

Systems and methods are provided for determining whether a volume of biological sample is adequate to produce an accurate analyte concentration measurement. Certain such systems and methods provide the additional function of compensating for a sample volume determined to be less than adequate in order to proceed with an accurate analyte concentration measurement. The present invention is employed with a biosensor, such as an electrochemical test strip to which the sample volume of biological solution is deposited, and a meter configured to receive such test strip and to measure the concentration of selected analytes within the biological sample.

Devices, systems, methods, and software for providing remote medical diagnosis and therapy to a subject comprising: a module for conducting telecommunications with a telemedicalist; a module for applying a diagnostic or a therapeutic analysis; an apparatus for dispensing one or more medical items from an inventory of medical items, the inventory of medical items risk profiled to a subject, a population, a venue, or a situation; and optionally, a biosensor apparatus.

The invention provides sensor, preferably biosensor devices and method of fabrication. The devices have significant advantages over the prior art methods having compatibility with future trends in clinical diagnostics and chemical detection. The underlying principle involves the integration of nanometer diameter, micron long metal or semiconductor rods onto a substrate to form a suspended nanomechanical cantilevers. The cantilever rods are rigidly attached to the substrate on one or both ends, and resonate at a characteristic frequency depending on the diameter, length, and stiffness of the rod. The metal or semiconductor rods are integrated onto the substrate using electrofluidic or fluidic assembly techniques. A receptor coating is placed on the metal or semiconductor rods prior to or following rod alignment using self-assembly chemistries. Sensing is accomplished when the target agent binds to the receptor substance, causing a change in the mass of the cantilever rod, and a corresponding change in the resonant frequency. This change in resonant frequency can be detected using an electrical readout. The sensing circuitry is integrated with CMOS or TFT technologies to form compact multi-analyte senor arrays on single crystal silicon, glass, or polymeric substrates. Circuits can also be included on the substrate to transmit the array data via wireless methods to a remote workstation for analysis. Devices may be integrated on chips with other analysis devices.

Implantable medical devices for cardiac care are provided that include a housing having a power source and control electronics; at least one lead extending from the housing and having one or more discrete reservoirs therein, each reservoir having an opening to an outer surface of the lead; one or more sensors, which monitor or detects an analyte, biomarker, or physical parameter that is associated with cardiac health, located in the reservoirs and in operable communication with said control electronics; and at least one selectively disintegratable reservoir cap sealing each of the reservoir openings, wherein the reservoir cap is operably connected to the power source and control electronics to disintegrate the reservoir cap and expose the sensors in vivo. The sensor may detect an analyte or biomarker selected from potassium ion, sodium ion, lithium ion, magnesium ion, ammonium ion, ionized calcium, lactate, oxygen, carbon dioxide, and creatinine, urea, BUN, and bilirubin.

The present invention concerns a portable, reliable and sensitive biosensor apparatus. In certain embodiments, the apparatus incorporates a fluidic cube, comprising a vent cap, vent cap isolator, cube body, waveguide and stage. In preferred embodiments, the fluidic cube further comprises a fluid manifold. In more preferred embodiments, the fluidic cube comprises one or more sample channels that are designed to increase fluid mixing through the use of baffles. The biosensor is designed to simultaneously process multiple samples for a variety of analytes. In certain embodiments, the biosensor is designed to operate as a compact, stand-alone automated unit that can reliably analyze environmental, clinical, veterinary, pathologic or medical samples under adverse field conditions.

Disclosed are methods and devices for detection of bacteria based on recognition and infection of one or more selected strains of bacteria with bacteriophage genetically modified to cause production of an inducer molecule in the bacterium following phage infection. The inducer molecule is released from the infected bacterium and is detected by genetically modified bacterial bioreporter cells designed to emit bioluminescence upon stimulation by the inducer. Autoamplification of the bioluminescent signal permits detection of low levels of bacteria without sample enrichment. Also disclosed are methods of detection for select bacteria, and kits for detection of select bacteria based on the described technology.

Methods of producing liquid handling biosensor devices are provided. The liquid handling biosensor devices allow detection of biomolecular interactions in liquid. The use of labels is not required and the methods can be performed in a high-throughput manner.

A biosensor that includes a light transmissive electrocardiographic electrode and a light transmissive insulating film that detect an electrical signal relating to an electrocardiographic signal through capacitive coupling that are disposed above light emitting elements and a light receiving element that detect an optical detection signal relating to a photo-plethysmographic signal. When a user brings a finger into contact with a contact surface of the light transmissive insulating film, the electrical signal relating to the electrocardiographic signal is detected by the light transmissive electrocardiographic electrode. At the same time, reflected light emitted from the light emitting elements after being reflected from the user's finger are received by the light receiving element to detect an optical detection signal corresponding to the received reflected lights so that biological information is generated based on both the electrocardiographic signal and a photo-plethysmographic signal.

This invention relates to the biosensor devices, their fabrication and use. The biosensor devices comprise a substrate supporting an array of microwells where each microwell can contain a biocompatible fluid and a membrane having a membrane protein of interest. In use the microwells can be addressable to detect and analyze a variety of analytes.

The invention discloses analyte measuring electrochemical bio-sensing test paper with a blood volume ratio correcting function, a biosensor device, a system and a method. The test paper comprises a first group of electrodes for detecting the concentration of an analyte and a second group of electrodes for detecting a blood volume ratio concentration, wherein the first group of electrodes and the second group of electrodes correspond to different reaction regions respectively; a reaction layer reacting with a substance to be measured is only covered on the first group of electrodes; and first signals including a direct current signal are supplied to the first group of electrodes and second signals including a fixed-frequency alternating current signal are supplied to the second group of electrodes, so that an analyte concentration and a blood volume ratio which are not corrected are further measured respectively and a more accurate analyte concentration corrected by a blood volume ratio is obtained.

An enhanced diffraction based biosensor system and method are provided for detecting an analyte of interest in a test medium. The system incorporates at least one additional detection tag substance with the analyte of interest, the tag emitting a measurable parameter that is different from optical diffraction characteristics of the analyte. The biosensor may be a “fluoroptical” system wherein the detection tag is a fluorescence emitting substance, including fluorescent-labeled diffraction enhancing elements. The enhanced diffraction biosensor system may determine the presence of analytes in biological fluids both qualitatively and quantitatively.

Devices, systems, and methods for detecting protein-nucleic acid and cell-nucleic acid hybridization, using surface-tethered aptamer probes, without the use of labeling or target modification and capable of recycling.